Inhibrx Biosciences Inc.
INBX | NASDAQ
$115.23
+$3.19 (+2.85%)
Sep 22, 2026, 10:52 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -138.18M | -130.19M | -140.06M | -155.09M | -163.69M | 1.69B | 1.66B | 1.7B | 1.69B | -194.06M | -154.96M | -188.67M | -172.21M | -153.58M | -145.23M | -125.5M | -110.76M | -93.73M | -81.77M | -78.23M | -78.15M | -75.32M |
Depreciation & Amortization | 2.21M | 2.35M | 2.48M | 2.61M | 2.79M | 2.6M | 2.28M | 1.89M | 1.44M | 1.26M | 1.19M | 1.2M | 1.2M | 1.21M | 1.23M | 1.23M | 1.22M | 1.21M | 1.2M | 1.15M | 1.1M | 1.05M |
Stock-Based Compensation | 11.68M | 11.34M | 11.14M | 11.38M | 11.17M | 55.93M | 59.87M | 59.16M | 62.73M | 22.4M | 20.69M | 23.77M | 21.94M | 20.03M | 20.45M | 19.28M | 18.08M | 16.74M | 15.05M | 12.24M | 10.05M | 7.36M |
Other Working Capital | -16.1M | -19.83M | -4.56M | -594K | 10.99M | 33.51M | 33.79M | 42.89M | 23.96M | 1.08M | -621K | -9.17M | -775K | 6.55M | 3.75M | 1.73M | 2.21M | -1.13M | n/a | -2.47M | -2.23M | -4.35M |
Other Non-Cash Items | 6.25M | 4.5M | 4.25M | 3.6M | 3.01M | -1.97B | -1.97B | -1.97B | -1.97B | 3.05M | 1.77M | 6.64M | 6.4M | 4.62M | 5.09M | 52K | -613K | -1.08M | -1.42M | 2.44M | 6.23M | 10.25M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9K | -9K | -9K | 502K | -2.18M |
Change in Working Capital | -13.84M | -19.93M | -7.61M | -5.9M | 6.89M | 48.18M | 52.05M | 67.36M | 47.03M | 2.25M | 2.31M | -10.03M | -1.01M | 12.42M | 3.16M | -2.38M | 1.91M | -8.74M | -13.37M | -10.68M | -13.04M | -3.39M |
Operating Cash Flow | -131.89M | -131.93M | -129.79M | -143.39M | -139.85M | -167.25M | -194.41M | -143.21M | -167.17M | -165.12M | -129.01M | -167.09M | -143.68M | -115.3M | -115.3M | -107.32M | -90.16M | -85.62M | -80.32M | -73.09M | -73.3M | -62.23M |
Capital Expenditures | 17K | -10K | -31K | -47K | -284K | -1.5M | -2.6M | -6.02M | -6.59M | -5.69M | -4.59M | -1.42M | -587K | -592K | -686K | -686K | -875K | -967K | -864K | -1.21M | -1.34M | -1.29M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 3K | 3K | 3K | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 55K | 55K | 55K | 55K | n/a |
Investing Cash Flow | 20K | -7K | -28K | -44K | -284K | -1.5M | -2.6M | -6.02M | -6.59M | -5.69M | -4.59M | -1.42M | -587K | -592K | -686K | -686K | -875K | -912K | -809K | -1.15M | -1.28M | -1.29M |
Debt Repayment | 74.99M | 74.99M | 99.97M | 99.97M | 99.97M | 99.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 352K | 352K | 227K | 227K | -125K | -125K | n/a | -67.5M | 132.39M | 106.64M | 133.24M | 359.4M | 160.02M | 245.93M | 258.55M | 141.38M | 141.69M | 122.01M | 83.77M | 59.28M | 194.68M | 171.08M |
Financial Cash Flow | 78.67M | 77.07M | 101.45M | 100.19M | 99.84M | 132.79M | 71.68M | 4.18M | 204.07M | 145.37M | 133.6M | 359.76M | 160.38M | 246.29M | 258.55M | 141.38M | 141.69M | 122.01M | 83.77M | 59.28M | 194.68M | 171.08M |
Net Cash Flow | -53.22M | -54.86M | -28.38M | -43.24M | -40.29M | -35.96M | -125.33M | -418.92M | -243.56M | -25.44M | -39.61M | 425.51M | 250.36M | 90.79M | 142.56M | 33.37M | 50.66M | 35.48M | 2.64M | -14.97M | 120.1M | 107.56M |
Free Cash Flow | -131.87M | -131.94M | -129.83M | -143.44M | -140.13M | -168.75M | -197.01M | -149.23M | -173.76M | -170.81M | -133.6M | -168.51M | -144.27M | -115.89M | -115.99M | -108.01M | -91.03M | -86.58M | -81.19M | -74.3M | -74.64M | -63.52M |
Adj. Free Cash Flow | -143.55M | -143.28M | -140.96M | -154.82M | -151.3M | -224.68M | -256.88M | -208.39M | -236.49M | -193.21M | -154.29M | -192.28M | -166.2M | -135.92M | -136.44M | -127.29M | -109.11M | -103.32M | -96.24M | -86.54M | -84.69M | -70.87M |
Maintenance CapEx | -37K | -10K | -31K | -47K | -284K | -1.39M | -2.49M | -4.49M | -5.06M | -4.26M | -3.17M | -1.42M | -587K | -592K | -644.4K | -602.62K | -791.62K | -883.62K | -822.22K | -597K | -428K | -14K |
Growth CapEx | 54K | n/a | n/a | n/a | n/a | -107.24K | -107.24K | -1.53M | -1.53M | -1.42M | -1.42M | n/a | n/a | n/a | -41.6K | -83.38K | -83.38K | -83.38K | -41.78K | -612K | -911K | -1.27M |
Owner Earnings | -131.93M | -131.94M | -129.83M | -143.44M | -140.13M | -168.65M | -196.9M | -147.7M | -172.23M | -169.38M | -132.18M | -168.51M | -144.27M | -115.89M | -115.95M | -107.92M | -90.95M | -86.5M | -81.15M | -73.69M | -73.73M | -62.24M |
Add to Watchlist
Select watchlists to add or remove INBX